Pfizer Stock Prediction and Forecast [PFE]

AI-generated source summary

The analysis suggests that Pfizer (PFE) is facing bearish conditions. Since September 12, 2025, the system ranks it as a sell candidate with a score of -2.6. The stock is at the lower end of a horizontal trend. Breaking below $23.44 would signal a strong sell, whereas the anticipated 3-month change is an approximate 1.18% change. The expected 12-month change is -15.82%, varying between -$31.11 and -$9.34. The latest daily data shows a -3.98% decrease to $23.87, and the weekly volatility is 2.03%, with a very low-risk assessment. Trading volume also increased significantly. The latest analyst ratings were neutral and the insider power for the stock is 41.889. There are sell signals from both short and long term Moving Averages. Resistance is at $24.57 and $24.67. There is no stop-loss suggestion.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   13 Sept 2025, 03:13 UTC

   The analyst published the original source item.

2. First prediction resolved

   22 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   22 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:13 UTC

   Tahlil Plus began monitoring the extracted predictions.